To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Dec 5, 2024
Introduced in House
Dec 5, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 10305: To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-10305/
"H.R. 10305: To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-10305/.
H.R. 10305, 118th Cong. (2026), https://openamerica.io/bill/118-HR-10305/.
[H.R. 10305: To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.](https://openamerica.io/bill/118-HR-10305/)